This table presents recent patent oppositions filed by Alexion Pharmaceuticals, Inc. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP2708559Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 31, 2018
EP2708558Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 21, 2018
EP2552955Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 2, 2018

The following table provides an overview of the latest patents of Alexion Pharmaceuticals, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3167888May 1, 2024Behandlung Von Patienten Mit Paroxysmaler Nachtlicher Hamoglobinurie Mit Einem Komplementinhibitor1
EP2894165Jan 4, 2023Methods And Compositions For Treating Complement-Associated Disorders2
EP2978451Nov 27, 2019Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C52
EP3207132Jul 31, 2019Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof1